Michael J. Fox Foundation Advances Parkinson’s Research with Precision Medicine
The Michael J. Fox Foundation launched the Parkinson’s Progression Markers Initiative in 2010, which has evolved into the Parkinson’s Precision Medicine Initiative. With over 4,200 clinical participants and 47,000 online contributors, it focuses on personalized treatments based on biological differences, aiming to innovate clinical trials and improve Parkinson’s disease therapies. Data has been downloaded 50 million times.
TOI World·



